Informatica $10bn IPO: CEO Walia explains why it’s time to go public again “with a nice flower on my tux”
Informatica has become a public company again six years after it was taken private in...
Analysis
Africa has seen the largest growth in central nervous system related trials over the past decade
We've analysed 10 years' worth of clinical trials data from GlobalData to pick out key...
Covid-19: vaccine pricing varies wildly by country and company
As the vaccine inequity debate rages on, even nations with access to Covid-19 jabs are...
3D printing: What is the executive and medical view on the tech in healthcare?
GlobalData stats point to 3D printing becoming a $32bn industry by 2025, rising to over...
Healthcare industry finds a cure for businesses’ sustainability woes
When it comes to sustainability in healthcare, one may literally find the roots of hope...
Cloud hiring levels in the pharmaceutical industry rose to a year-high in August 2021
42.7% of the companies included in our analysis recruiting for at least one cloud-related position.
Robotics hiring levels in the pharmaceutical industry rose in August 2021
19.6% of the companies included in our analysis recruited for at least one robotics-related position.
Babies from a Covid-19 mRNA vaccinated pregnancy will still need primary jabs
Covid-19 vaccinated parents pass on antibodies to their babies but titres are likely to have waned at six months.
Merck’s molnupiravir: Covid-19 gamechanger status relies on patient risk factors
Molnupiravir access may depend on how risk factors are interpreted but availability could be wider with the help of pharmacists
Pharma’s reliance on horseshoe crabs is threatening the species
Conservationists say using the prehistoric creatures’ blood for bacterial endotoxin testing is no longer justifiable.
Novavax at risk of losing time advantage once Covid-19 vaccine competitors flex production muscle
Competitor protein subunit Covid-19 vaccine manufacturers are slowly closing in at Novavax’s lead.
